Inhibition of the Cyclin K‐CDK12 complex induces DNA damage and increases the effect of androgen deprivation therapy in prostate cancer
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Inhibition of the Cyclin K‐CDK12 complex induces DNA damage and increases the effect of androgen deprivation therapy in prostate cancer
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF CANCER
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2023-11-02
DOI
10.1002/ijc.34778
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Emerging systemic treatment for metastatic castration-resistant prostate cancer: a review of recent randomized controlled trials
- (2023) Takafumi Yanagisawa et al. CURRENT OPINION IN UROLOGY
- Prognostic and clinicopathological value of CDK12 mutation in prostate cancer: a meta-analysis
- (2023) Wenjian Zhang et al. Expert Review of Anticancer Therapy
- Cancer statistics, 2022
- (2022) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Talazoparib plus enzalutamide in metastatic castration-resistant prostate cancer: TALAPRO-2 phase III study design
- (2022) Neeraj Agarwal et al. Future Oncology
- CYCLIN K down-regulation induces androgen receptor gene intronic polyadenylation, variant expression and PARP inhibitor vulnerability in castration-resistant prostate cancer
- (2022) Rui Sun et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- CRISPR screening identifies CDK12 as a conservative vulnerability of prostate cancer
- (2021) Hanqi Lei et al. Cell Death & Disease
- Nivolumab Reduces PD1 Expression and Alters Density and Proliferation of Tumor Infiltrating Immune Cells in a Tissue Slice Culture Model of Renal Cell Carcinoma
- (2021) Philipp J. Stenzel et al. Cancers
- Heterogeneity of genomic profile in patients with HER2-positive breast cancer
- (2020) Bo Chen et al. ENDOCRINE-RELATED CANCER
- Olaparib for Metastatic Castration-Resistant Prostate Cancer
- (2020) Johann de Bono et al. NEW ENGLAND JOURNAL OF MEDICINE
- DNA Damage Promotes TMPRSS2-ERG Oncoprotein Destruction and Prostate Cancer Suppression via Signaling Converged by GSK3β and WEE1
- (2020) Zhe Hong et al. MOLECULAR CELL
- EAU-EANM-ESTRO-ESUR-SIOG Guidelines on Prostate Cancer—2020 Update. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent
- (2020) Nicolas Mottet et al. EUROPEAN UROLOGY
- CDK12 phosphorylates 4E-BP1 to enable mTORC1-dependent translation and mitotic genome stability
- (2019) Seung H. Choi et al. GENES & DEVELOPMENT
- CDK12 controls G1/S progression by regulating RNAPII processivity at core DNA replication genes
- (2019) Anil Paul Chirackal Manavalan et al. EMBO REPORTS
- CDK12 loss in cancer cells affects DNA damage response genes through premature cleavage and polyadenylation
- (2019) Malgorzata Krajewska et al. Nature Communications
- CDK12 inhibition mediates DNA damage and is synergistic with sorafenib treatment in hepatocellular carcinoma
- (2019) Cun Wang et al. GUT
- Targeting CDK12-mediated transcription regulation in anaplastic thyroid carcinoma
- (2019) Meijuan Geng et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- EWS/FLI Confers Tumor Cell Synthetic Lethality to CDK12 Inhibition in Ewing Sarcoma
- (2018) Amanda Balboni Iniguez et al. CANCER CELL
- Inactivation of CDK12 Delineates a Distinct Immunogenic Class of Advanced Prostate Cancer
- (2018) Yi-Mi Wu et al. CELL
- Olaparib combined with abiraterone in patients with metastatic castration-resistant prostate cancer: a randomised, double-blind, placebo-controlled, phase 2 trial
- (2018) Noel Clarke et al. LANCET ONCOLOGY
- Cyclin K regulates prereplicative complex assembly to promote mammalian cell proliferation
- (2018) Tingjun Lei et al. Nature Communications
- Role of Androgen Receptor in Prostate Cancer: A Review
- (2018) Kazutoshi Fujita et al. World Journal of Mens Health
- Genomic analysis of DNA repair genes and androgen signaling in prostate cancer
- (2018) Kasey Jividen et al. BMC CANCER
- State-of-the-art strategies for targeting the DNA damage response in cancer
- (2018) Patrick G. Pilié et al. Nature Reviews Clinical Oncology
- Cyclin K dependent regulation of Aurora B affects apoptosis and proliferation by induction of mitotic catastrophe in prostate cancer
- (2017) Sabrina Schecher et al. INTERNATIONAL JOURNAL OF CANCER
- WNT signalling in prostate cancer
- (2017) Virginia Murillo-Garzón et al. Nature Reviews Urology
- Ovarian Cancers Harboring Inactivating Mutations inCDK12Display a Distinct Genomic Instability Pattern Characterized by Large Tandem Duplications
- (2016) Tatiana Popova et al. CANCER RESEARCH
- Covalent targeting of remote cysteine residues to develop CDK12 and CDK13 inhibitors
- (2016) Tinghu Zhang et al. Nature Chemical Biology
- Reduced PAK1 activity sensitizes FA/BRCA-proficient breast cancer cells to PARP inhibition
- (2016) Olga Villamar et al. Oncotarget
- Characterization of Human Cyclin-Dependent Kinase 12 (CDK12) and CDK13 Complexes in C-Terminal Domain Phosphorylation, Gene Transcription, and RNA Processing
- (2015) Kaiwei Liang et al. MOLECULAR AND CELLULAR BIOLOGY
- Ovarian carcinoma CDK12 mutations misregulate expression of DNA repair genes via deficient formation and function of the Cdk12/CycK complex
- (2015) Kingsley M. Ekumi et al. NUCLEIC ACIDS RESEARCH
- Cyclin D1 expression in prostate carcinoma
- (2014) R.A. Pereira et al. BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH
- Comparative Genomic and Transcriptomic Analyses of LNCaP and C4-2B Prostate Cancer Cell Lines
- (2014) Lien Spans et al. PLoS One
- A Distinct Expression Pattern of Cyclin K in Mammalian Testes Suggests a Functional Role in Spermatogenesis
- (2014) Xiaocong Xiang et al. PLoS One
- Genome-wide Profiling of Genetic Synthetic Lethality Identifies CDK12 as a Novel Determinant of PARP1/2 Inhibitor Sensitivity
- (2013) I. Bajrami et al. CANCER RESEARCH
- Optimization and comprehensive characterization of a faithful tissue culture model of the benign and malignant human prostate
- (2013) Sophia Lisette Maund et al. LABORATORY INVESTIGATION
- A Hormone-DNA Repair Circuit Governs the Response to Genotoxic Insult
- (2013) J. F. Goodwin et al. Cancer Discovery
- Androgen Receptor Signaling Regulates DNA Repair in Prostate Cancers
- (2013) W. R. Polkinghorn et al. Cancer Discovery
- PTEN in DNA damage repair
- (2012) Mei Ming et al. CANCER LETTERS
- Cyclin K goes with Cdk12 and Cdk13
- (2012) Jiri Kohoutek et al. Cell Division
- The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data: Figure 1.
- (2012) Ethan Cerami et al. Cancer Discovery
- The Cyclin K/Cdk12 complex maintains genomic stability via regulation of expression of DNA damage response genes
- (2011) D. Blazek et al. GENES & DEVELOPMENT
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started